Send us a link
Critics of current methods for evaluating researchers’ work say a system that relies on bibliometric parameters favours a ‘quantity over quality’ approach, and undervalues achievements such as social impact and leadership.
The pandemic has worsened longstanding sexist and racist inequalities in science pushing many of us to say 'I'm done', write 35 female scientists
Competition and conflicts of interest distort too many medical findings
Before we present this week's Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads…
Institutions are letting their financial and reputational worries cloud their judgment about when they can safely reopen.
Inequality made historical pandemics 'worse than they had to be'.
Studies of social networks show that opposition to vaccines is small but far-reaching - and growing.
A deluge of poor quality research is sabotaging an effective evidence based response.
The hunt is on for better ways to collect and search pandemic studies
Predatory publishing has emerged as a professional problem for academics and their institutions, as well as a broader societal concern, bringing to the fore a debate over what constitutes legitimate science.
In collaboration with SPARC Europe, a survey to map Open Access (OA) and Open Science (OS) infrastructure across Europe was launched. The aim is to establish a core understanding of Europe's current field of Open resources and gain insight into their usage, durability, and adherence to core open principles and standards.
Business Secretary Alok Sharma has announced that Professor Dame Ottoline Leyser DBE FRS will join UK Research and Innovation as its new Chief Executive. She will succeed Sir Mark Walport who announced in September last year that he would retire in 2020. Professor Leyser will start her new role on Monday June 29.
The pandemic will negatively impact the careers of women in STEM, particularly those of color, and failure to respond could jeopardize years of progress toward faculty equity.
The man behind Trump's favorite unproven treatment has made a great career assailing orthodoxy. His claim of a 100 percent cure rate shocked scientists around the world.
Many female academics say juggling their career with coronavirus childcare is overwhelming.
The pandemic is devastating economies. As countries look to revive growth, recovery must go with - not against - the grain of nature.
Current and former moderators will all be paid a minimum of $1,000. Selena Scola filed the case in California.
The extreme metabolism of some snakes could provide leads on how to regenerate human tissue.
For the sake of both science and action in the COVID-19 pandemic, we need collaboration among specialists, not sects.
In a secret experiment, researchers replaced the dysfunctional brain cells of a Parkinson's patient with the progeny of an extraordinary type of stem cell.
An immunization shot is still in development, but debate over who gets priority has already begun.
New initiative couples rapid release of new results with expert review.
Elisabeth Bik quit her job to spot errors in research papers - and has become the public face of image sleuthing.
Virologist Peter Piot, director of the London School of Hygiene & Tropical Medicine, fell ill with COVID-19 in mid-March.
Machine-learning models trained on normal behavior are showing cracks —forcing humans to step in to set them straight.
Scottish researchers have taken aim at a study reporting surprising findings on COVID-19 - but what it took to correct the record is all too familiar.
Academic research is fundamental to learn more about the nature of the coronavirus.
Officials are under pressure to restart the economy, but many states are moving too quickly, researchers say. The costs may be measured in lost lives.
